March 22, 2024 Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure read more
March 4, 2024 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease read more
February 29, 2024 Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 read more
February 26, 2024 Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance read more
February 26, 2024 Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease read more
February 16, 2024 Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call read more
November 13, 2023 Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum read more